<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Kidney transplantation in children: Outcomes</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Kidney transplantation in children: Outcomes</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Kidney transplantation in children: Outcomes</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ruth A McDonald, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Patrick Niaudet, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 19, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Kidney transplantation remains the best treatment for children with end-stage kidney disease. Kidney allograft and patient survival have increased with improvements in the care of young patients and advances in immunosuppressive therapy. (See  <a class="medical medical_review" href="/z/d/html/16179.html" rel="external">"Overview of kidney replacement therapy for children with chronic kidney disease", section on 'Preemptive transplantation as preferred kidney replacement therapy modality'</a>.)</p><p>Outcome of kidney transplantation and the factors that affect allograft and patient survival in children will be reviewed here.</p><p>General principles of immunosuppression and complications of kidney transplantation in children are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6120.html" rel="external">"Kidney transplantation in children: General principles"</a> and  <a class="medical medical_review" href="/z/d/html/6128.html" rel="external">"Kidney transplantation in children: Immunosuppression"</a> and  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications"</a>.)</p><p>In addition, issues of kidney transplantation survival and outcome that are common to both children and adults are presented in separate topic reviews. (See  <a class="medical medical_review" href="/z/d/html/7302.html" rel="external">"Kidney transplantation in adults: Risk factors for graft failure"</a> and  <a class="medical medical_review" href="/z/d/html/7355.html" rel="external">"Kidney transplantation in adults: HLA matching and outcomes"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">FACTORS AFFECTING ALLOGRAFT SURVIVAL</span><span class="headingEndMark"> — </span>The outcome of kidney transplantation in children has improved over the last several decades [<a href="#rid1">1-5</a>]. This was illustrated in a study based on data from the United States Scientific Registry of Transplant Recipients that reported improvements of one-year graft survival for transplants performed in 1987 versus 2010 (81 versus 97 percent), five-year graft survival for transplants performed in 1987 versus 2006 (59 versus 78 percent), and 10-year graft survival for transplants performed in 1987 versus 2001 (47 versus 60 percent) [<a href="#rid2">2</a>]. (See  <a class="medical medical_review" href="/z/d/html/6128.html" rel="external">"Kidney transplantation in children: Immunosuppression"</a> and <a class="local">'Effect of immunosuppressive regimens'</a> below.)</p><p>Factors that affect allograft survival in children include the following [<a href="#rid6">6-16</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Improved immunosuppressive regimen</p><p class="bulletIndent1"><span class="glyph">●</span>Source (living versus deceased donor) of donor kidney and age of donor</p><p class="bulletIndent1"><span class="glyph">●</span>Preemptive transplant</p><p class="bulletIndent1"><span class="glyph">●</span>Human leukocyte antigen (HLA) compatibility</p><p class="bulletIndent1"><span class="glyph">●</span>Recipient factors (eg, age and race [<a href="#rid17">17</a>])</p><p class="bulletIndent1"><span class="glyph">●</span>Delayed graft function (DGF)</p><p class="bulletIndent1"><span class="glyph">●</span>Acute rejection</p><p class="bulletIndent1"><span class="glyph">●</span>Infections</p><p class="bulletIndent1"><span class="glyph">●</span>Adherence</p><p class="bulletIndent1"><span class="glyph">●</span>Repeat transplant [<a href="#rid18">18</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Underlying primary disease</p><p></p><p class="headingAnchor" id="H3"><span class="h2">Effect of immunosuppressive regimens</span><span class="headingEndMark"> — </span>Since the earlier days of pediatric kidney transplantation, the development of the immunosuppressive agents used in current practice improved allograft survival [<a href="#rid7">7,10,16,19-23</a>]. In particular, the use of calcineurin inhibitors (particularly <a class="drug drug_pediatric" data-topicid="12822" href="/z/d/drug information/12822.html" rel="external">tacrolimus</a>) and the change in antimetabolite agent from <a class="drug drug_pediatric" data-topicid="12923" href="/z/d/drug information/12923.html" rel="external">azathioprine</a> to <a class="drug drug_pediatric" data-topicid="12624" href="/z/d/drug information/12624.html" rel="external">mycophenolate</a> mofetil have reduced the incidence of acute rejection and graft survival [<a href="#rid10">10,22,23</a>]. Immunosuppressive agents and their effects on graft survival are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6128.html" rel="external">"Kidney transplantation in children: Immunosuppression"</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Donor source and age</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Living versus deceased donor</strong> – Allograft survival is higher in children with living donor allografts compared with those with deceased donor allografts, with reported 9 to 35 percent improvement in five- to seven-year allograft survival rates [<a href="#rid10">10,24,25</a>]. Despite the general desirability of living donor allografts, a deceased donor may be preferred in settings in which there is a high risk of recurrent disease leading to loss of the allograft, as with rapidly progressive focal glomerulosclerosis. Support for this exception is provided by the finding that five-year allograft survival of living and deceased donor allografts was not significantly different for children with focal glomerulosclerosis (69 and 60 percent) [<a href="#rid26">26</a>]. Other diseases with a high recurrence rate in the allograft include atypical hemolytic uremic syndrome and primary hyperoxaluria. (See  <a class="medical medical_review" href="/z/d/html/6120.html" rel="external">"Kidney transplantation in children: General principles", section on 'Donor choice'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Donor age</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Deceased donors</strong> – Poorer allograft survival is associated with the transplantation of kidney allografts from deceased donors younger than two years of age or older than 50 years of age [<a href="#rid27">27,28</a>]. In the former, poorer allograft survival may be due to a higher incidence of primary nonfunction and allograft thrombosis.</p><p></p><p class="bulletIndent2">Data from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry showed the following five-year allograft survival of kidneys from deceased donors based on donor ages [<a href="#rid10">10</a>]:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>&lt;2 years of age – 51 percent</p><p class="bulletIndent3"><span class="glyph">-</span>2 to 17 years of age – 68 percent</p><p class="bulletIndent3"><span class="glyph">-</span>18 to 49 years of age – 73 percent</p><p class="bulletIndent3"><span class="glyph">-</span>≥50 years of age – 58 percent</p><p></p><p class="bulletIndent2">In a study based on United Network for Organ Sharing data from 1987 to 2003, en bloc kidney transplantation compared with single kidney had a lower rate of DGF and better five-year allograft survival when deceased donors were younger than five years of age [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Living donors</strong> – In contrast with data regarding deceased donors, allograft failure is similar in older living donors (age 50 to 75 years of age) compared with younger-aged living donors [<a href="#rid30">30</a>].</p><p></p><p class="headingAnchor" id="H3053794062"><span class="h2">Preemptive transplant</span><span class="headingEndMark"> — </span>Several studies have reported improved allograft and patient survival of preemptive transplantation compared with transplantation performed after treatment with dialysis, as illustrated by the following [<a href="#rid12">12-15,31,32</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For first kidney transplants in children, the Eurotransplant registry reported a six-year graft survival of 82 percent in patients receiving a preemptive transplant compared with 69 percent in those undergoing dialysis [<a href="#rid31">31</a>]. Preemptive transplantation also resulted in lower rates of acute rejections (52 percent versus 37 percent rejection-free at three years).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Multivariate analysis of data from the United States Renal Data System showed that preemptive transplantation was associated with lower allograft failure (hazard ratio 0.75, 95% CI 0.64-91) and mortality (hazard ratio 0.59, 95% CI 0.43-0.82) compared with children on dialysis for &gt;1 year or those on dialysis &gt;18 months over a median four-year follow-up [<a href="#rid32">32</a>].</p><p></p><p class="headingAnchor" id="H5"><span class="h2">Human leukocyte antigen matches</span><span class="headingEndMark"> — </span>Similarly to adults, superior HLA matching between recipient and donor, whether deceased donor or living related, is associated with improved allograft outcomes in children [<a href="#rid33">33-38</a>]. (See  <a class="medical medical_review" href="/z/d/html/7355.html" rel="external">"Kidney transplantation in adults: HLA matching and outcomes"</a>.)</p><p>Identical HLA matches result in the best outcomes. However, children rarely have brothers or sisters (some of whom are HLA identical) old enough to be an organ donor; as a result, most living donated allografts are from a parent, who is an obligate one haplotype match. Optimal HLA matching is preferred to minimize sensitization, particularly for young recipients who will need retransplantation [<a href="#rid34">34-36</a>]. (See  <a class="medical medical_review" href="/z/d/html/7355.html" rel="external">"Kidney transplantation in adults: HLA matching and outcomes", section on 'Long-term graft survival'</a>.)</p><p>The impact on HLA matching for pediatric kidney transplantation was highlighted by an analysis from the United Kingdom Transplant Registry that reported better 10-year graft survival rates from deceased donors with only zero to one HLA mismatches versus living donors with four to six HLA mismatches [<a href="#rid37">37</a>].</p><p>However, maximization of HLA matching is not entirely beneficial for those awaiting a deceased donor allograft. Restricting deceased donor offers to only well HLA-matched donors may significantly prolong the transplant candidate's wait time, increasing morbidities associated with end-stage kidney disease and dialysis. In addition, improved matching may not prolong long-term graft survival in children who receive deceased donor allograft [<a href="#rid39">39,40</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Recipient factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Age</strong> – In the past, the results of kidney transplantation in children appear to vary with the age of the recipient, with younger recipients having poorer outcome [<a href="#rid10">10,41</a>]. With the improvement in care, similar excellent long-term allograft survival to that of older children is seen in young children [<a href="#rid42">42-44</a>], especially in those who receive living donor kidneys [<a href="#rid10">10,42</a>].</p><p></p><p class="bulletIndent1">Data from 2014 NAPRTCS registry show the following five-year survival rates based on donor source and recipient age [<a href="#rid10">10</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Living related donor, recipient age between:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>0 to 1 year of age – 84 percent</p><p class="bulletIndent3"><span class="glyph">-</span>2 to 5 years of age – 86 percent</p><p class="bulletIndent3"><span class="glyph">-</span>6 to 12 years of age – 84 percent</p><p class="bulletIndent3"><span class="glyph">-</span>&gt;12 years of age – 79 percent</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Deceased donor, recipient age between:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>0 to 1 year of age – 63 percent</p><p class="bulletIndent3"><span class="glyph">-</span>2 to 5 years of age – 75 percent</p><p class="bulletIndent3"><span class="glyph">-</span>6 to 12 years of age – 73 percent</p><p class="bulletIndent3"><span class="glyph">-</span>&gt;12 years of age – 68 percent</p><p></p><p class="bulletIndent1">For adolescents who are at increased risk of allograft failure, contributory factors include nonadherence and transition to adult care during this vulnerable period [<a href="#rid41">41,45-49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Race – In the United States, multivariate analysis of data from the United States Renal Data System (kidney transplant from 2000 through September, 2011) reported that Black children had poorer graft survival over a median follow-up time of 4.5 years compared with White and Hispanic children [<a href="#rid17">17</a>]. This analysis controlled for neighborhoods based on income level and source of health care insurance (public versus private).</p><p></p><p class="headingAnchor" id="H8"><span class="h2">Delayed graft function</span><span class="headingEndMark"> — </span>DGF, defined by the need of dialysis during the first week or first 72 hours following transplantation, is associated with poor outcome [<a href="#rid11">11,50,51</a>]. Causes of DGF include postischemic acute kidney injury, vascular thrombosis of the renal artery or vein, urologic complications (ie, urinary leak or obstruction), and, rarely, hyperacute rejection due to preformed anti-HLA antibodies. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Delayed graft function'</a>.)</p><p>It occurs more frequently in patients who receive deceased donor allograft, and the incidence of DGF increases with cold ischemia time. In the NAPRTCS cohort, the five-year allograft survival was lower in patients receiving a deceased donor allograft with a cold ischemic time greater than 24 hours compared with those with a lower cold ischemic time (63 versus 72 percent) [<a href="#rid10">10</a>]. Intraoperative vascular volume maintenance is most important to prevent DGF, especially in young recipients.</p><p class="headingAnchor" id="H9"><span class="h2">Acute rejection episodes</span><span class="headingEndMark"> — </span>In the 2014 NAPRTCS report, the rate of allograft failure or death due to acute rejection was 5 percent in children who received living donor kidneys and 8 percent in those with deceased donor kidneys [<a href="#rid10">10</a>]. In another cohort of children who received deceased donor allografts, the estimated allograft half-life was shorter in patients who had acute rejection episodes than in those who did not (6.6 versus 12.5 years) [<a href="#rid52">52</a>]. An analysis of Organ Procurement and Transplant Network [<a href="#rid11">11</a>] data also showed an increased relative risk of allograft failure for pediatric recipients who were treated for acute rejection in the first years post-transplant [<a href="#rid11">11</a>]. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Acute rejection'</a>.)</p><p>In addition to acutely threatening survival of the allograft, acute rejection episodes markedly increase the risk of developing chronic rejection, thereby enhancing possible allograft loss over time. In one study of nearly 3500 children, multivariate analyses found that the relative risks of chronic rejection increased with an acute rejection episode and were even greater with two such episodes (relative risk 3.1 and 4.3, respectively) [<a href="#rid53">53</a>]. Given this association, the prevention of such events by providing optimal immunosuppressive therapy is extremely important. The beneficial effects of improved immunosuppressive regimens and optimal HLA matching on allograft survival are, in part, because of their role in lowering the risk of acute rejection. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Chronic allograft injury'</a> and  <a class="medical medical_review" href="/z/d/html/6128.html" rel="external">"Kidney transplantation in children: Immunosuppression"</a> and  <a class="medical medical_review" href="/z/d/html/7359.html" rel="external">"Kidney transplantation in adults: Chronic allograft nephropathy", section on 'Alloantigen-dependent factors'</a>.)</p><p class="headingAnchor" id="H10"><span class="h2">Infections</span><span class="headingEndMark"> — </span>Infections are a permanent risk in patients receiving immunosuppressive treatment and may impact allograft survival. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Infections'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Cytomegalovirus infection is associated with increased mortality and morbidity [<a href="#rid54">54</a>]. Prophylaxis of cytomegalovirus infection may be associated with improved patient and allograft survival. (See  <a class="medical medical_review" href="/z/d/html/7300.html" rel="external">"Clinical manifestations, diagnosis, and management of cytomegalovirus disease in kidney transplant patients"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Polyomavirus, mainly BK polyomavirus, affects 3 to 8 percent of children with kidney allografts and may be responsible for allograft nephropathy and allograft failure. Risk factors for BK polyomavirus infection are intense immunosuppression and acute rejection. (See  <a class="medical medical_review" href="/z/d/html/7338.html" rel="external">"Kidney transplantation in adults: BK polyomavirus-associated nephropathy"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, there appears to be no correlation between a history of urinary tract infection (either before or after transplant) and decreased allograft survival [<a href="#rid55">55</a>]. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Urinary tract infection'</a>.)</p><p></p><p class="headingAnchor" id="H11"><span class="h2">Nonadherence</span><span class="headingEndMark"> — </span>Nonadherence to immunosuppressive treatment contributes to both acute and chronic rejection. An analysis of the United States Renal Data System showed that, among pediatric kidney transplant recipients, greater adherence was significantly associated with improved long-term allograft survival [<a href="#rid56">56</a>].</p><p>A systematic review of the literature that identified 16 studies reported a wide range of nonadherence from 5 to 70 percent [<a href="#rid57">57</a>]. Among these studies, there was variability in how adherence was assessed (eg, drug level assays, pill counting, patient self-reporting). Factors associated with nonadherence included:</p><p class="bulletIndent1"><span class="glyph">●</span>Poor socioeconomic status</p><p class="bulletIndent1"><span class="glyph">●</span>Family/caregiver stress and conflicts</p><p class="bulletIndent1"><span class="glyph">●</span>Lack of parental\caregiver supervision</p><p class="bulletIndent1"><span class="glyph">●</span>Patient depression</p><p class="bulletIndent1"><span class="glyph">●</span>Cosmetic side effects of medications</p><p class="bulletIndent1"><span class="glyph">●</span>Large number of medications</p><p class="bulletIndent1"><span class="glyph">●</span>Size of tablets and difficulty swallowing tablets</p><p class="bulletIndent1"><span class="glyph">●</span>Taste of medication</p><p class="bulletIndent1"><span class="glyph">●</span>Poor patient knowledge</p><p class="bulletIndent1"><span class="glyph">●</span>Striving for increased autonomy and independence</p><p></p><p>Nonadherence is a risk factor for graft loss [<a href="#rid14">14,24,48,49,57,58</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>In the 2010 NAPRTCS transplant report, 5 percent of primary allograft loss was due to patient discontinuation of medications.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study based on Organ Procurement and Transplantation Network data, 3.4 percent of allografts in pediatric Black recipients were lost due to nonadherence as a contributory factor compared with 1.5 percent among other races [<a href="#rid24">24</a>]. Significantly lower incidence of nonadherence was observed in children under the age of 10 (0.9 percent) when compared with early adolescents aged 10 to 14 (2.2 percent) and older teenagers aged 15 to 20 (2 percent).</p><p></p><p>Although it is clear from the above evidence that increasing adherence would improve kidney transplantation outcome, data on interventions to improve adherence are lacking. One study conducted in adult transplant recipients showed that a multidimensional program including home visits, follow-up calls, and educational material resulted in a lower nonadherence in the intervention group compared with the control group over the three-month study period [<a href="#rid59">59</a>]. However, the differences between the two groups faded after nine months.</p><p class="headingAnchor" id="H1998303675"><span class="h2">Primary disease</span><span class="headingEndMark"> — </span>Allograft survival may be altered due to the underlying primary disease:</p><p class="bulletIndent1"><span class="glyph">●</span>Increased risk of recurrent disease is associated with focal glomerulosclerosis, atypical (complement-mediated) hemolytic uremic syndrome, and membranoproliferative glomerulonephritis, which may lead to kidney allograft failure [<a href="#rid60">60</a>]. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Recurrence of primary disease'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with hyperoxaluria, oxalate continues to deposit in the transplant unless concomitant or sequential liver transplantation has been performed. (See  <a class="medical medical_review" href="/z/d/html/6141.html" rel="external">"Primary hyperoxaluria", section on 'Transplantation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In contrast, although lower urinary tract malformations (eg, posterior urethral valves) are associated with bladder complications leading to potential urinary leaks and obstruction and infection, these do not appear to alter long-term allograft function [<a href="#rid61">61-63</a>]. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Urologic complications'</a> and  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Surgical and urologic sequelae'</a> and  <a class="medical medical_review" href="/z/d/html/6574.html" rel="external">"Management of posterior urethral valves", section on 'Renal transplantation'</a>.)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">PATIENT SURVIVAL</span><span class="headingEndMark"> — </span>Patient survival is better in pediatric kidney transplant recipients than in adults, and mortality has decreased [<a href="#rid1">1,41,64-69</a>]. Data from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) 2014 annual report showed that, for those transplanted since 1996, the three-year patient survival exceeded 98 percent in all recipients of living related or deceased donors [<a href="#rid10">10</a>]. The three-year survival rate has significantly improved for infants who received deceased donor allograft, from 78.6 percent for those transplanted between 1987 and 1995 to 94.8 percent in the cohort transplanted after 1996 [<a href="#rid10">10</a>]. The data from the United States showed similar improvements of patient survival, with five-year patient survival after receiving a first transplant of 90 percent in 1987, 93 percent between 1990 and 1994, and 95 percent between 1995 and 2004 [<a href="#rid2">2,70</a>].</p><p>Centers from other countries report similar results of improved patient survival in young children [<a href="#rid71">71-73</a>].</p><p>Survival with a functioning graft in children receiving a first kidney transplant has also increased [<a href="#rid70">70</a>]. In the United States, the survival rate with a functioning graft in children receiving a first kidney allograft from 1990 to 2010 was 82 percent over a median follow-up time of 8.4 years [<a href="#rid70">70</a>].</p><p>Mortality remains higher for infants compared with older children [<a href="#rid1">1,10</a>]. This was illustrated by the following three-year survival rates of children registered in the NAPRTCS database who were transplanted between 1996 and 2013, as follows [<a href="#rid10">10</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Living donor</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>All recipients – 98 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients ≤1 year of age – 96 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients between 2 and 5 years of age – 98 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients between 6 and 12 years of age – 98 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients &gt;12 years of age – 98 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Deceased donor</strong>:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>All recipients – 98 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients ≤1 year of age – 95 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients between 2 and 5 years of age – 96 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients between 6 and 12 years of age – 99 percent</p><p class="bulletIndent2"><span class="glyph">•</span>Recipients &gt;12 years of age – 98 percent</p><p></p><p>As with adults, survival is superior among children with a kidney allograft compared with those who remain on dialysis. This was best shown in an observational study of nearly 6000 patients under 19 years of age who were placed on the kidney transplant waiting list [<a href="#rid74">74</a>]. Compared with those who remained on the list, a significantly lower mortality rate was noted in those who underwent transplantation (13.1 versus 17.6 deaths/1000 patient-years). This survival benefit was observed beginning six months post-transplant.</p><p>Overall, the major causes of death are cardiovascular disease, infection, and malignancy [<a href="#rid10">10,75-78</a>]. The main causes of death during the first three months are infections (principally cytomegalovirus infection) and hemorrhage. However, the incidences of malignancies and cardiovascular disease are lower when compared with those reported for adults. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Acute rejection'</a>.)</p><p>Non-kidney manifestations of the underlying disease also may have an effect on patient survival. In one study comparing patient survival rates of children with and without autosomal recessive polycystic kidney disease (ARPKD), death resulting from sepsis due to cholangitis and liver involvement was a factor in those with ARPKD [<a href="#rid79">79</a>].</p><p>Mortality after transplantation is also affected by the underlying kidney disease, with higher mortality rates observed for oxalosis, congenital nephrotic syndrome, and Drash syndrome [<a href="#rid80">80</a>].</p><p class="headingAnchor" id="H13"><span class="h1">GROWTH AFTER KIDNEY TRANSPLANTATION</span><span class="headingEndMark"> — </span>Although most children have improved statural growth after successful kidney transplantation, approximately one-half will attain normal height [<a href="#rid81">81</a>]. Factors associated with complete catch-up growth include excellent kidney allograft function (normal or almost normal glomerular filtration rate), corticosteroid-free immunosuppressive therapy, young age of recipient (less than six years of age), and living donor source [<a href="#rid81">81-83</a>]. (See  <a class="medical medical_review" href="/z/d/html/83284.html" rel="external">"Growth failure in children with chronic kidney disease: Prevention and management", section on 'Reducing glucocorticoid exposure'</a> and  <a class="medical medical_review" href="/z/d/html/6128.html" rel="external">"Kidney transplantation in children: Immunosuppression", section on 'Glucocorticoid-sparing regimen'</a>.)</p><p>Recombinant growth hormone therapy may be beneficial in improving growth in prepubertal children with growth impairment after kidney transplantation. (See  <a class="medical medical_review" href="/z/d/html/6140.html" rel="external">"Growth failure in children with chronic kidney disease: Treatment with growth hormone"</a>.)</p><p class="headingAnchor" id="H3905699232"><span class="h1">OTHER COMPLICATIONS</span><span class="headingEndMark"> — </span>Other long-term complications following kidney transplantation in children include hypertension, cardiovascular disease, recurrent infection, malignancy, type 2 diabetes, mineral-bone disorders, surgical sequelae, and recurrence of the primary disease, which affect graft survival. These are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immunosuppression effect on graft survival</strong> – The outcome of kidney transplantation in children has improved over the last several decades, a period that coincides with the introduction and widespread use of calcineurin inhibitors and other immunosuppressive agents. (See <a class="local">'Effect of immunosuppressive regimens'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other factors affecting graft survival</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Donor source and age</strong> – Allograft survival is better with kidneys from living versus deceased donors. Poorer allograft survival is associated with kidney allografts from deceased donors younger than two years of age or older than 50 years of age. In the former, poorer allograft survival may be due to a higher incidence of primary nonfunction and allograft thrombosis. (See <a class="local">'Donor source and age'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Preemptive transplant</strong> – Preemptive transplant is associated with improved allograft and patient survival compared with transplantation performed after dialysis treatment. (See <a class="local">'Preemptive transplant'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Human leukocyte antigen (HLA) match</strong> – Better histocompatibility matching between donor and recipient improves allograft survival, with the possible exception of deceased donor allografts. (See <a class="local">'Human leukocyte antigen matches'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Recipient factors</strong> – Although the overall allograft survival is excellent for recipients of all ages, infants and adolescent recipients have a poorer allograft survival rate. In the United States, Black children have a poorer allograft survival rate compared with White and Hispanic children. (See <a class="local">'Recipient factors'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Delayed graft function (DGF)</strong> – DGF, defined by the need of dialysis during the first week or first 72 hours following transplantation, is associated with poor outcome. Causes of DGF include postischemic acute kidney injury, vascular thrombosis of the renal artery or vein, urologic complications (ie, urinary leak or obstruction), and, rarely, hyperacute rejection due to preformed anti-HLA antibodies. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications", section on 'Delayed graft function'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Acute rejection</strong> – Acute rejection episodes are associated with acute allograft loss. In addition, acute rejection is associated with chronic rejection and graft loss. (See <a class="local">'Acute rejection episodes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Infections</strong> – Infections due to cytomegalovirus or polyomavirus, mainly BK polyomavirus, are associated with decreased allograft survival time. However, urinary tract infections are not associated with graft loss. (See <a class="local">'Infections'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonadherence</strong> – Nonadherence to immunosuppressive treatment contributes to both acute and chronic rejection. (See <a class="local">'Nonadherence'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Primary disease</strong> – Increased allograft failure may be due to recurrent disease associated with focal glomerulosclerosis, atypical (complement-mediated) hemolytic uremic syndrome, membranoproliferative glomerulonephritis, and primary oxaluria. (See <a class="local">'Primary disease'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Patient survival</strong> – Patient survival is better in pediatric kidney transplant recipients than in adults and has increased. The major causes of death are infection and cardiopulmonary disease. (See <a class="local">'Patient survival'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Growth impairment</strong> – Most children have improved statural growth after successful kidney transplantation. Catch-up growth is only observed with normal or nearly normal allograft function. The most important factors limiting growth after kidney transplantation are poor kidney allograft function and corticosteroid therapy. (See <a class="local">'Growth after kidney transplantation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other complications</strong> – Children who receive a kidney allograft are at risk for long-term complications that include hypertension, cardiovascular disease, recurrent infection, malignancy, type 2 diabetes, mineral-bone disorders, and surgical sequelae, which may affect graft survival. (See  <a class="medical medical_review" href="/z/d/html/6143.html" rel="external">"Kidney transplantation in children: Complications"</a>.)</p><p></p><p class="headingAnchor" id="H16463248"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Patrick Niaudet, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Harmon WE, McDonald RA, Reyes JD, et al. Pediatric transplantation, 1994-2003. Am J Transplant 2005; 5:887.</a></li><li><a class="nounderline abstract_t">Van Arendonk KJ, Boyarsky BJ, Orandi BJ, et al. National trends over 25 years in pediatric kidney transplant outcomes. Pediatrics 2014; 133:594.</a></li><li><a class="nounderline abstract_t">Mehrabi A, Kashfi A, Tönshoff B, et al. Long-term results of paediatric kidney transplantation at the University of Heidelberg: a 35 year single-centre experience. Nephrol Dial Transplant 2004; 19 Suppl 4:iv69.</a></li><li><a class="nounderline abstract_t">Rees L. Long-term outcome after renal transplantation in childhood. Pediatr Nephrol 2009; 24:475.</a></li><li><a class="nounderline abstract_t">Rees L, Shroff R, Hutchinson C, et al. Long-term outcome of paediatric renal transplantation: follow-up of 300 children from 1973 to 2000. Nephron Clin Pract 2007; 105:c68.</a></li><li><a class="nounderline abstract_t">Warady BA, Hébert D, Sullivan EK, et al. Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 1997; 11:49.</a></li><li><a class="nounderline abstract_t">Hwang AH, Cho YW, Cicciarelli J, et al. Risk factors for short- and long-term survival of primary cadaveric renal allografts in pediatric recipients: a UNOS analysis. Transplantation 2005; 80:466.</a></li><li><a class="nounderline abstract_t">Omoloja A, Mitsnefes M, Talley L, et al. Racial differences in graft survival: a report from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Clin J Am Soc Nephrol 2007; 2:524.</a></li><li><a class="nounderline abstract_t">Ellis EN, Martz K, Talley L, et al. Factors related to long-term renal transplant function in children. Pediatr Nephrol 2008; 23:1149.</a></li><li class="breakAll">Emmes. The North American Pediatric Renal Trials and Collaborative Studies 2014 Annual Report. Available at: https://web.emmes.com/study/ped/annlrept/annlrept.html (Accessed on October 02, 2015).</li><li><a class="nounderline abstract_t">Butani L, Perez RV. Effect of pretransplant dialysis modality and duration on long-term outcomes of children receiving renal transplants. Transplantation 2011; 91:447.</a></li><li><a class="nounderline abstract_t">Schurman SJ, McEnery PT. Factors influencing short-term and long-term pediatric renal transplant survival. J Pediatr 1997; 130:455.</a></li><li><a class="nounderline abstract_t">Mahmoud A, Saïd MH, Dawahra M, et al. Outcome of preemptive renal transplantation and pretransplantation dialysis in children. Pediatr Nephrol 1997; 11:537.</a></li><li><a class="nounderline abstract_t">Vats AN, Donaldson L, Fine RN, Chavers BM. Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation 2000; 69:1414.</a></li><li><a class="nounderline abstract_t">Lofaro D, Jager KJ, Abu-Hanna A, et al. Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. Nephrol Dial Transplant 2016; 31:317.</a></li><li><a class="nounderline abstract_t">Broyer M, Ehrich J, Jones E, Selwood N. Five year survival of kidney transplantation in children: data from the European (EDTA-ERA) Registry. Kidney Int Suppl 1993; 43:S22.</a></li><li><a class="nounderline abstract_t">Patzer RE, Mohan S, Kutner N, et al. Racial and ethnic disparities in pediatric renal allograft survival in the United States. Kidney Int 2015; 87:584.</a></li><li><a class="nounderline abstract_t">Tejani A, Sullivan EK. Factors that impact on the outcome of second renal transplants in children. Transplantation 1996; 62:606.</a></li><li><a class="nounderline abstract_t">Tejani A, Stablein DM, Donaldson L, et al. Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience. Clin Transpl 1999; :95.</a></li><li><a class="nounderline abstract_t">Colombani PM, Dunn SP, Harmon WE, et al. Pediatric transplantation. Am J Transplant 2003; 3 Suppl 4:53.</a></li><li><a class="nounderline abstract_t">Tejani A, Ho PL, Emmett L, et al. Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Am J Transplant 2002; 2:142.</a></li><li><a class="nounderline abstract_t">Jungraithmayr TC, Wiesmayr S, Staskewitz A, et al. Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation. Transplantation 2007; 83:900.</a></li><li><a class="nounderline abstract_t">Filler G, Webb NJ, Milford DV, et al. Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion. Pediatr Transplant 2005; 9:498.</a></li><li><a class="nounderline abstract_t">Hardy BE, Shah T, Cicciarelli J, et al. Kidney transplantation in children and adolescents: an analysis of United Network for Organ Sharing Database. Transplant Proc 2009; 41:1533.</a></li><li><a class="nounderline abstract_t">Dale-Shall AW, Smith JM, McBride MA, et al. The relationship of donor source and age on short- and long-term allograft survival in pediatric renal transplantation. Pediatr Transplant 2009; 13:711.</a></li><li><a class="nounderline abstract_t">Baum MA, Stablein DM, Panzarino VM, et al. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001; 59:328.</a></li><li><a class="nounderline abstract_t">Harmon WE, Stablein D, Alexander SR, Tejani A. Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1991; 51:406.</a></li><li><a class="nounderline abstract_t">Rao KV, Kasiske BL, Odlund MD, et al. Influence of cadaver donor age on posttransplant renal function and graft outcome. Transplantation 1990; 49:91.</a></li><li><a class="nounderline abstract_t">Dharnidharka VR, Stevens G, Howard RJ. En-bloc kidney transplantation in the United states: an analysis of united network of organ sharing (UNOS) data from 1987 to 2003. Am J Transplant 2005; 5:1513.</a></li><li><a class="nounderline abstract_t">Chesnaye NC, van Stralen KJ, Bonthuis M, et al. The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study. Nephrol Dial Transplant 2017; 32:1949.</a></li><li><a class="nounderline abstract_t">Cransberg K, Smits JM, Offner G, et al. Kidney transplantation without prior dialysis in children: the Eurotransplant experience. Am J Transplant 2006; 6:1858.</a></li><li><a class="nounderline abstract_t">Amaral S, Sayed BA, Kutner N, Patzer RE. Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease. Kidney Int 2016; 90:1100.</a></li><li><a class="nounderline abstract_t">Shi X, Liu R, Xie X, et al. Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis. Nephrol Dial Transplant 2017; 32:1939.</a></li><li><a class="nounderline abstract_t">Gralla J, Tong S, Wiseman AC. The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients. Transplantation 2013; 95:1218.</a></li><li><a class="nounderline abstract_t">Tagliamacco A, Cioni M, Comoli P, et al. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant. Transpl Int 2014; 27:667.</a></li><li><a class="nounderline abstract_t">Foster BJ, Dahhou M, Zhang X, et al. Relative importance of HLA mismatch and donor age to graft survival in young kidney transplant recipients. Transplantation 2013; 96:469.</a></li><li><a class="nounderline abstract_t">Opelz G, Döhler B, Middleton D, et al. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants. Transplantation 2017; 101:2789.</a></li><li><a class="nounderline abstract_t">Vu LT, Baxter-Lowe LA, Garcia J, et al. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation. Arch Surg 2011; 146:824.</a></li><li><a class="nounderline abstract_t">Gritsch HA, Veale JL, Leichtman AB, et al. Should pediatric patients wait for HLA-DR-matched renal transplants? Am J Transplant 2008; 8:2056.</a></li><li><a class="nounderline abstract_t">Opelz G, Döhler B. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation 2010; 90:292.</a></li><li><a class="nounderline abstract_t">Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005; 5:843.</a></li><li><a class="nounderline abstract_t">Hogan J, Bacchetta J, Charbit M, et al. Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age. Nephrol Dial Transplant 2018; 33:1459.</a></li><li><a class="nounderline abstract_t">Larkins NG, Wong G, Alexander SI, et al. Survival and transplant outcomes among young children requiring kidney replacement therapy. Pediatr Nephrol 2021; 36:2443.</a></li><li><a class="nounderline abstract_t">Pickles CW, Brown C, Marks SD, et al. Long term outcomes following kidney transplantation in children who weighed less than 15 kg - report from the UK Transplant Registry. Pediatr Nephrol 2023; 38:3803.</a></li><li><a class="nounderline abstract_t">Smith JM, Ho PL, McDonald RA, North American Pediatric Renal Transplant Cooperative Study. Renal transplant outcomes in adolescents: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2002; 6:493.</a></li><li><a class="nounderline abstract_t">Koshy SM, Hebert D, Lam K, et al. Renal allograft loss during transition to adult healthcare services among pediatric renal transplant patients. Transplantation 2009; 87:1733.</a></li><li><a class="nounderline abstract_t">Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children. N Engl J Med 2014; 371:549.</a></li><li><a class="nounderline abstract_t">Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S. Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005; 9:381.</a></li><li><a class="nounderline abstract_t">Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009; 9:35.</a></li><li><a class="nounderline abstract_t">Tejani AH, Sullivan EK, Alexander SR, et al. Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatr Transplant 1999; 3:293.</a></li><li><a class="nounderline abstract_t">Lim WH, McDonald SP, Kennedy SE, et al. Association Between Slow and Delayed Graft Function With Graft Outcomes in Pediatric and Adolescent Deceased Donor Kidney Transplant Recipients. Transplantation 2017; 101:1906.</a></li><li><a class="nounderline abstract_t">Lindholm A, Ohlman S, Albrechtsen D, et al. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens. Transplantation 1993; 56:307.</a></li><li><a class="nounderline abstract_t">Tejani A, Cortes L, Stablein D. Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 1996; 61:1054.</a></li><li><a class="nounderline abstract_t">Höcker B, Zencke S, Krupka K, et al. Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir. Transplantation 2016; 100:862.</a></li><li><a class="nounderline abstract_t">Silva A, Rodig N, Passerotti CP, et al. Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults. J Urol 2010; 184:1462.</a></li><li><a class="nounderline abstract_t">Chisholm-Burns MA, Spivey CA, Rehfeld R, et al. Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients. Am J Transplant 2009; 9:2497.</a></li><li><a class="nounderline abstract_t">Dobbels F, Ruppar T, De Geest S, et al. Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review. Pediatr Transplant 2010; 14:603.</a></li><li><a class="nounderline abstract_t">Varnell CD Jr, Rich KL, Zhang B, et al. Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication. Pediatr Nephrol 2021; 36:2453.</a></li><li><a class="nounderline abstract_t">De Geest S, Schäfer-Keller P, Denhaerynck K, et al. Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant 2006; 20:359.</a></li><li><a class="nounderline abstract_t">Van Stralen KJ, Verrina E, Belingheri M, et al. Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population. Nephrol Dial Transplant 2013; 28:1031.</a></li><li><a class="nounderline abstract_t">Cornwell LB, Ingulli EG, Mason MD, et al. Renal Transplants Due to Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Have Better Graft Survival Than Non-CAKUT Controls: Analysis of Over 10,000 Patients. Urology 2021; 154:255.</a></li><li><a class="nounderline abstract_t">Marchal S, Kalfa N, Iborra F, et al. Long-term Outcome of Renal Transplantation in Patients with Congenital Lower Urinary Tract Malformations: A Multicenter Study. Transplantation 2020; 104:165.</a></li><li><a class="nounderline abstract_t">Jahromi MS, Velasquez MC, Blachman-Braun R, et al. Pediatric Kidney Transplantation Outcomes in Children with Primary Urological Abnormalities Versus Nonurological Abnormalities: Long-Term Results. J Urol 2020; 203:406.</a></li><li><a class="nounderline abstract_t">Najarian JS, So SK, Simmons RL, et al. The outcome of 304 primary renal transplants in children (1968-1985). Ann Surg 1986; 204:246.</a></li><li><a class="nounderline abstract_t">Englund M, Berg U, Tydén G. A longitudinal study of children who received renal transplants 10-20 years ago. Transplantation 2003; 76:311.</a></li><li><a class="nounderline abstract_t">Potter DE, Najarian J, Belzer F, et al. Long-term results of renal transplantation in children. Kidney Int 1991; 40:752.</a></li><li><a class="nounderline abstract_t">Broyer M. Kidney transplantation in children--data from the EDTA registry. The EDTA Registry Committee. Transplant Proc 1989; 21:1985.</a></li><li><a class="nounderline abstract_t">Churchill BM, Sheldon CA, McLorie GA, Arbus GS. Factors influencing patient and graft survival in 300 cadaveric pediatric renal transplants. J Urol 1988; 140:1129.</a></li><li><a class="nounderline abstract_t">Rigden SPA, Ward GM, Turner C, et al. Twenty years experience of renal transplantation in children. Pediatr Nephrol 1989; 3:C229.</a></li><li><a class="nounderline abstract_t">Laskin BL, Mitsnefes MM, Dahhou M, et al. The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States. Kidney Int 2015; 87:575.</a></li><li><a class="nounderline abstract_t">Dall'Amico R, Ginevri F, Ghio L, et al. Successful renal transplantation in children under 6 years of age. Pediatr Nephrol 2001; 16:1.</a></li><li><a class="nounderline abstract_t">Neipp M, Offner G, Lück R, et al. Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation 2002; 73:409.</a></li><li><a class="nounderline abstract_t">Becker T, Neipp M, Reichart B, et al. Paediatric kidney transplantation in small children-- a single centre experience. Transpl Int 2006; 19:197.</a></li><li><a class="nounderline abstract_t">Gillen DL, Stehman-Breen CO, Smith JM, et al. Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation. Am J Transplant 2008; 8:2600.</a></li><li><a class="nounderline abstract_t">Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study. Kidney Int 2002; 61:621.</a></li><li><a class="nounderline abstract_t">Harzallah K, Floret D, Martin X, Cochat P. [Mortality in pediatric renal transplants: 15 years' experience]. Arch Pediatr 2004; 11:916.</a></li><li><a class="nounderline abstract_t">Van Damme-Lombaerts R, Herman J, Coosemans W, Pirenne J. Pediatric renal transplantation: a single Belgian center experience over 20 years. Pediatr Transplant 2001; 5:447.</a></li><li><a class="nounderline abstract_t">Neu AM. Special issues in pediatric kidney transplantation. Adv Chronic Kidney Dis 2006; 13:62.</a></li><li><a class="nounderline abstract_t">Davis ID, Ho M, Hupertz V, Avner ED. Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease. Pediatr Transplant 2003; 7:364.</a></li><li><a class="nounderline abstract_t">Tejani A, Sullivan EK, Alexander S, et al. Posttransplant deaths and factors that influence the mortality rate in North American children. Transplantation 1994; 57:547.</a></li><li><a class="nounderline abstract_t">Bonthuis M, Groothoff JW, Ariceta G, et al. Growth Patterns After Kidney Transplantation in European Children Over the Past 25 Years: An ESPN/ERA-EDTA Registry Study. Transplantation 2020; 104:137.</a></li><li><a class="nounderline abstract_t">Tejani A, Fine R, Alexander S, et al. Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study. J Pediatr 1993; 122:397.</a></li><li><a class="nounderline abstract_t">Pape L, Ehrich JH, Zivicnjak M, Offner G. Growth in children after kidney transplantation with living related donor graft or cadaveric graft. Lancet 2005; 366:151.</a></li></ol></div><div id="topicVersionRevision">Topic 6135 Version 40.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15760416" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Pediatric transplantation, 1994-2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24616363" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : National trends over 25 years in pediatric kidney transplant outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15240854" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Long-term results of paediatric kidney transplantation at the University of Heidelberg: a 35 year single-centre experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17687572" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Long-term outcome after renal transplantation in childhood.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17135771" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Long-term outcome of paediatric renal transplantation: follow-up of 300 children from 1973 to 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9035173" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16123719" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Risk factors for short- and long-term survival of primary cadaveric renal allografts in pediatric recipients: a UNOS analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699460" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Racial differences in graft survival: a report from the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18301925" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Factors related to long-term renal transplant function in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18301925" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Factors related to long-term renal transplant function in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21131898" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Effect of pretransplant dialysis modality and duration on long-term outcomes of children receiving renal transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9063424" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Factors influencing short-term and long-term pediatric renal transplant survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9323275" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Outcome of preemptive renal transplantation and pretransplantation dialysis in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10798764" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pretransplant dialysis status and outcome of renal transplantation in North American children: a NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26320038" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8246364" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Five year survival of kidney transplantation in children: data from the European (EDTA-ERA) Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25337773" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Racial and ethnic disparities in pediatric renal allograft survival in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8830823" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Factors that impact on the outcome of second renal transplants in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11038628" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Steady improvement in short-term graft survival of pediatric renal transplants: the NAPRTCS experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12694050" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Pediatric transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12099516" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Reduction in acute rejections decreases chronic rejection graft failure in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17460560" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16048603" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19545673" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Kidney transplantation in children and adolescents: an analysis of United Network for Organ Sharing Database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19207226" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The relationship of donor source and age on short- and long-term allograft survival in pediatric renal transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11135087" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1994535" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Graft thrombosis in pediatric renal transplant recipients. A report of the North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2301036" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Influence of cadaver donor age on posttransplant renal function and graft outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15888062" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : En-bloc kidney transplantation in the United states: an analysis of united network of organ sharing (UNOS) data from 1987 to 2003.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28992338" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The association of donor and recipient age with graft survival in paediatric renal transplant recipients in a European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplantation Association Registry study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16771812" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Kidney transplantation without prior dialysis in children: the Eurotransplant experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27653837" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28992320" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Effect of human leukocyte antigen mismatching on the outcomes of pediatric kidney transplantation: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23478360" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The impact of human leukocyte antigen mismatching on sensitization rates and subsequent retransplantation after first graft failure in pediatric renal transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24629017" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23759881" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Relative importance of HLA mismatch and donor age to graft survival in young kidney transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28471872" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21768429" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18839440" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Should pediatric patients wait for HLA-DR-matched renal transplants?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20548266" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15760412" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Trends and results for organ donation and transplantation in the United States, 2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29617835" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Patient and transplant outcome in infants starting renal replacement therapy before 2 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33649894" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Survival and transplant outcomes among young children requiring kidney replacement therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37209174" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Long term outcomes following kidney transplantation in children who weighed less than 15 kg - report from the UK Transplant Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12453202" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Renal transplant outcomes in adolescents: a report of the North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19502968" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Renal allograft loss during transition to adult healthcare services among pediatric renal transplant patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25099579" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Kidney transplantation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15910397" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19133930" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Nonadherence consensus conference summary report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10562974" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27575687" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Association Between Slow and Delayed Graft Function With Graft Outcomes in Pediatric and Adolescent Deceased Donor Kidney Transplant Recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8356584" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants treated by 3 cyclosporine regimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8623184" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26736017" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Cytomegalovirus Infection in Pediatric Renal Transplantation and the Impact of Chemoprophylaxis With (Val-)Ganciclovir.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20727542" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19681814" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20214741" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Adherence to the immunosuppressive regimen in pediatric kidney transplant recipients: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33501558" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Predicting acute rejection in children, adolescents, and young adults with a kidney transplant by assessing barriers to taking medication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16824155" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23300261" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33454356" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Renal Transplants Due to Congenital Anomalies of the Kidney and Urinary Tract (CAKUT) Have Better Graft Survival Than Non-CAKUT Controls: Analysis of Over 10,000 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30964838" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Long-term Outcome of Renal Transplantation in Patients with Congenital Lower Urinary Tract Malformations: A Multicenter Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31487221" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Pediatric Kidney Transplantation Outcomes in Children with Primary Urological Abnormalities Versus Nonurological Abnormalities: Long-Term Results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3530152" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The outcome of 304 primary renal transplants in children (1968-1985).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12883184" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A longitudinal study of children who received renal transplants 10-20 years ago.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1745026" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Long-term results of renal transplantation in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2652648" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Kidney transplantation in children--data from the EDTA registry. The EDTA Registry Committee.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3054157" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Factors influencing patient and graft survival in 300 cadaveric pediatric renal transplants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Twenty years experience of renal transplantation in children</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25317931" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : The mortality risk with graft function has decreased among children receiving a first kidney transplant in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11198593" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Successful renal transplantation in children under 6 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11884938" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16441768" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Paediatric kidney transplantation in small children-- a single centre experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18808405" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11849405" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Mortality and causes of death of end-stage renal disease in children: a Dutch cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15288081" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : [Mortality in pediatric renal transplants: 15 years' experience].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11765726" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Pediatric renal transplantation: a single Belgian center experience over 20 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16412972" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Special issues in pediatric kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14738296" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8116040" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Posttransplant deaths and factors that influence the mortality rate in North American children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30946218" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Growth Patterns After Kidney Transplantation in European Children Over the Past 25 Years: An ESPN/ERA-EDTA Registry Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8441094" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16005338" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Growth in children after kidney transplantation with living related donor graft or cadaveric graft.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
